Evaluation of the Efficiency of Nanomicellar Formulation of Fat-soluble Vitamins in Patients with Cystic Fibrosis: the Study Protocol for a Randomized Controlled Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2024 Jan 16

PMID 38229125

Authors

Mahsa Soleimanzadeh

Saeedeh Talebi

Mahmoud Reza Jaafari

Seyed Javad Sayedi

Maryam Emadzadeh

Hamid Reza Kianifar

Affiliations

Soon will be listed here.

Abstract

Background: Cystic fibrosis is an inherited disease, which is caused by the CFTR protein defects due to mutations in the CFTR gene. Along with CFTR dysfunction, exocrine pancreatic insufficiency plays a key role in persistent fat malabsorption in CF patients; therefore, deficiency of fat-soluble vitamins (A, D, E, and K) is still a therapeutic challenge. Even with efficient pancreatic enzyme medication and CF-specific vitamins, many patients with CF have fat-soluble vitamins deficiency. The present study aims to evaluate the efficiency of nanomicelle formulation of fat-soluble vitamins in children with CF in order to achieve the appropriate serum levels of these vitamins.

Methods: This prospective, single-blind control trial will be conducted at the Akbar Children's Hospital in Mashhad, Iran. Patients with CF will be enrolled based on the eligibility criteria. The control group will receive the standard formulation of fat-soluble vitamins similar to the routine CF treatment, and for the intervention group, the nanomicelle formulation of fat-soluble vitamins will be administered for 3 months. The primary outcome of this study is the measurement of serum levels of fat-soluble vitamins. The secondary outcomes are clinical assessment by the Shwachman-Kulczycki score, anthropometrics, and quality of life. Outcomes will be assessed before and after 3 months.

Discussion: Due to persistent fat-soluble vitamin deficiency in CF disease, the nanomicelle formulation could be proposed as a new delivery method of fat-soluble vitamins in the treatment of cystic fibrosis.

Trial Registration: Iranian Registry of Clinical Trials IRCT20220415054541N1. Registered on July 23, 2022.

References

Papas K, Kalbfleisch J, Mohon R . Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Dig Dis Sci. 2007; 52(2):347-52. DOI: 10.1007/s10620-006-9489-2. View

Rovner A, Stallings V, Schall J, Leonard M, Zemel B . Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr. 2007; 86(6):1694-9. DOI: 10.1093/ajcn/86.5.1694. View

Dougherty K, Schall J, Stallings V . Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis. Am J Clin Nutr. 2010; 92(3):660-7. PMC: 2921538. DOI: 10.3945/ajcn.2010.29350. View

Keogh R, Szczesniak R, Taylor-Robinson D, Bilton D . Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data. J Cyst Fibros. 2018; 17(2):218-227. PMC: 5885983. DOI: 10.1016/j.jcf.2017.11.019. View

Durie P . The pathophysiology of the pancreatic defect in cystic fibrosis. Acta Paediatr Scand Suppl. 1989; 363:41-4. DOI: 10.1111/apa.1989.78.s363.41. View

Mobasheri M, Attar H, Sorkhabadi S, Khamesipour A, Jaafari M . Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80. Molecules. 2015; 21(1):E6. PMC: 6273564. DOI: 10.3390/molecules21010006. View

Goncalves A, Roi S, Nowicki M, Dhaussy A, Huertas A, Amiot M . Fat-soluble vitamin intestinal absorption: absorption sites in the intestine and interactions for absorption. Food Chem. 2014; 172:155-60. DOI: 10.1016/j.foodchem.2014.09.021. View

Sommerburg O, Hammerling S, Schneider S, Okun J, Langhans C, Leutz-Schmidt P . CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis. Antioxidants (Basel). 2021; 10(3). PMC: 8003491. DOI: 10.3390/antiox10030483. View

Gaskin K, Durie P, Lee L, Hill R, FORSTNER G . Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology. 1984; 86(1):1-7. View

10.

Wilcken B . An evaluation of screening for cystic fibrosis. Prog Clin Biol Res. 1987; 254:201-15. View

11.

Huang S, Schall J, Zemel B, Stallings V . Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr. 2006; 148(4):556-559. DOI: 10.1016/j.jpeds.2005.11.016. View

12.

Graham-Maar R, Schall J, Stettler N, Zemel B, Stallings V . Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. Am J Clin Nutr. 2006; 84(1):174-82. DOI: 10.1093/ajcn/84.1.174. View

13.

Nowak J, Krzyzanowska-Jankowska P, Drzymala-Czyz S, Gozdzik-Spychalska J, Wojsyk-Banaszak I, Skorupa W . Fat-Soluble Vitamins in Standard vs. Liposomal Form Enriched with Vitamin K2 in Cystic Fibrosis: A Randomized Multi-Center Trial. J Clin Med. 2022; 11(2). PMC: 8777794. DOI: 10.3390/jcm11020462. View

14.

Krzyzanowska P, Pogorzelski A, Skorupa W, Moczko J, Grebowiec P, Walkowiak J . Exogenous and endogenous determinants of vitamin K status in cystic fibrosis. Sci Rep. 2015; 5:12000. PMC: 4498176. DOI: 10.1038/srep12000. View

15.

Shakeri A, Sahebkar A . Opinion Paper: Nanotechnology: A Successful Approach to Improve Oral Bioavailability of Phytochemicals. Recent Pat Drug Deliv Formul. 2015; 10(1):4-6. DOI: 10.2174/1872211309666150611120724. View

16.

Maqbool A, Graham-Maar R, Schall J, Zemel B, Stallings V . Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. J Cyst Fibros. 2007; 7(2):137-41. PMC: 4447209. DOI: 10.1016/j.jcf.2007.07.002. View

17.

Matel J, Milla C . Nutrition in cystic fibrosis. Semin Respir Crit Care Med. 2009; 30(5):579-86. DOI: 10.1055/s-0029-1238916. View

18.

Bertolaso C, Groleau V, Schall J, Maqbool A, Mascarenhas M, Latham N . Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention. J Pediatr Gastroenterol Nutr. 2013; 58(4):443-8. PMC: 4212898. DOI: 10.1097/MPG.0000000000000272. View